纳米材料增强的微针:糖尿病和肥胖症的新兴疗法
Mehrnaz Abbasi1, Divine Afunu Boka1, Hannah DeLoit2
1Department of Nutritional Sciences, College of Human Sciences, Auburn University, Auburn, AL 36849, USA.
Pharmaceutics
|October 26, 2024
概括
纳米材料增强的微针 (MNs) 为糖尿病和肥胖提供先进的药物输送系统 (DDS). 这些创新承诺个性化治疗,精确的管理和实时监测,克服当前的治疗挑战.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物输送系统 (DDS) 提高治疗效果,提高患者的服药性,并最大限度地减少副作用.
- 透皮药物递送系统 (TDDS),包括微针 (MNs),为慢性疾病提供非侵入性管理.
- 糖尿病和肥胖等代谢障碍对传统药物输送构成重大挑战.
研究的目的:
- 审查纳米材料增强的MNs用于管理糖尿病和肥胖的最新进展.
- 探索纳米技术与MN的整合,以改善药物输送.
- 讨论这些创新的DDS的挑战和未来前景.
主要方法:
- 微针 (MN) 技术开发用于有针对性和受控的药物释放.
- 纳米载体 (如脂质体,聚合物NP) 与MNs的集成.
- 开发具有可穿戴传感器和智能材料的混合系统.
主要成果:
- MNs促进无痛的胰岛素输送,持续的葡萄糖监测和糖尿病伤口愈合.
- 纳米材料增强的MNs使抗肥胖药物和纳米颗粒的持续通过皮肤传递成为可能.
- 混合和智能MN系统提高了代谢障碍的治疗效率和患者管理.
结论:
- 用纳米材料增强的MN代表了针对糖尿病和肥胖症个性化DDS的重大进步.
- 这些系统提供精确的管理和实时监测,提高患者的治疗结果.
- 生物相容性,可扩展性和监管批准方面的挑战需要解决,以便广泛实施.
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...